Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Korda

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Cell Reports. Medicine|May 8, 2026
Neuroplastic white matter changes in patients with major depression following lysergic acid diethylamide treatmentMihai Avram, Aurore Menegaux, Felix Müller, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|August 2, 2023
Effective Connectivity of Thalamocortical Interactions Following d-Amphetamine, LSD, and MDMA AdministrationMihai Avram, Felix Müller, Katrin H Preller, et al.
Molecular Psychiatry|September 11, 2024
Large-scale brain connectivity changes following the administration of lysergic acid diethylamide, d-amphetamine, and 3,4-methylenedioxyamphetamineMihai Avram, Lydia Fortea, Lea Wollner, et al.
Journal of Affective Disorders|July 29, 2025
Neutral sentiment on patient's speech can predict the depressive symptom severity transdiagnosticallyLea Mineur, Svea Horstmann, Berat Arslan, et al.
Schizophrenia Bulletin|August 26, 2025
Decoding Psychosis Risk: Neuroanatomical Correlates of the NAPLS-2 Calculator in the PRONIA CohortLisa-Maria Neuner, Clara Weyer, Lana Kambeitz-Ilankovic, et al.
Translational Psychiatry|February 12, 2026
Brain texture alterations predict subtle visual perceptual dysfunctions in recent onset psychosis and clinical high-risk stateRebekka Lencer, Andreas Sprenger, Inga Meyhöfer, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 18, 2022
The impact of visual dysfunctions in recent-onset psychosis and clinical high-risk state for psychosisJohanna M Schwarzer, Inga Meyhoefer, Linda A Antonucci, et al.
Brain : a Journal of Neurology|March 13, 2026
Biosignatures of cognitive basic symptoms mark a distinct neurodevelopmental pathway to schizophreniaNikolaos Koutsouleris, Clara Vetter, Madalina Buciuman, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Cell Reports. Medicine|May 8, 2026
Neuroplastic white matter changes in patients with major depression following lysergic acid diethylamide treatmentMihai Avram, Aurore Menegaux, Felix Müller, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|August 2, 2023
Effective Connectivity of Thalamocortical Interactions Following d-Amphetamine, LSD, and MDMA AdministrationMihai Avram, Felix Müller, Katrin H Preller, et al.
Molecular Psychiatry|September 11, 2024
Large-scale brain connectivity changes following the administration of lysergic acid diethylamide, d-amphetamine, and 3,4-methylenedioxyamphetamineMihai Avram, Lydia Fortea, Lea Wollner, et al.
Journal of Affective Disorders|July 29, 2025
Neutral sentiment on patient's speech can predict the depressive symptom severity transdiagnosticallyLea Mineur, Svea Horstmann, Berat Arslan, et al.
Schizophrenia Bulletin|August 26, 2025
Decoding Psychosis Risk: Neuroanatomical Correlates of the NAPLS-2 Calculator in the PRONIA CohortLisa-Maria Neuner, Clara Weyer, Lana Kambeitz-Ilankovic, et al.
Translational Psychiatry|February 12, 2026
Brain texture alterations predict subtle visual perceptual dysfunctions in recent onset psychosis and clinical high-risk stateRebekka Lencer, Andreas Sprenger, Inga Meyhöfer, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 18, 2022
The impact of visual dysfunctions in recent-onset psychosis and clinical high-risk state for psychosisJohanna M Schwarzer, Inga Meyhoefer, Linda A Antonucci, et al.
Brain : a Journal of Neurology|March 13, 2026
Biosignatures of cognitive basic symptoms mark a distinct neurodevelopmental pathway to schizophreniaNikolaos Koutsouleris, Clara Vetter, Madalina Buciuman, et al.
Pageof 2